Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P J Cox

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|April 22, 2026
Aortic displacement and hemodynamics are abnormal in patients with Marfan syndrome: a combined 4D bSSFP and 4D flow CMR studyD Bosshardt, R Merton, A J Nederveen, et al.
European Heart Journal|March 11, 2025
Epicardial adipose tissue and malignant ventricular arrhythmias in phospholamban p.(Arg14del) variant carriersBelend Mahmoud, Moniek G P J Cox, Remco de Brouwer, et al.
Haematologica|December 21, 2023
Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapyWillem P J Cox, Nils Evander, Dorette S Van Ingen Schenau, et al.
Journal of Cardiovascular Electrophysiology|April 1, 2008
Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteriaMoniek G P J Cox, Marcel R Nelen, Arthur A M Wilde, et al.
Medchemcomm|August 16, 2018
The discovery of a potent Na<sub>v</sub>1.3 inhibitor with good oral pharmacokineticsD C Pryde, N A Swain, P A Stupple, et al.
European Journal of Preventive Cardiology|February 19, 2025
The Role of Comorbidities and Lifestyle Factors in Disease Progression of Phospholamban CardiomyopathyBelend Mahmoud, Myrthe Y C van der Heide, Moniek G P J Cox, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 31, 2025
Three-dimensional distensibility of the aorta derived from four-dimensional cardiovascular magnetic resonance in young and middle-aged adults with Marfan syndromeDaan Bosshardt, Renske Merton, Bibi A Schreurs, et al.
Journal of Cardiovascular Electrophysiology|December 3, 2024
Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and ManagementSteven A Muller, Giorgia Bertoli, Jianan Wang, et al.
Cardiology|November 14, 2012
Clinical and genetic characterization of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy caused by a plakophilin-2 splice mutationJasper J van der Smagt, Paul A van der Zwaag, J Peter van Tintelen, et al.
Heart Rhythm|December 29, 2012
Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype?Judith A Groeneweg, Paul A van der Zwaag, Jan D H Jongbloed, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|April 22, 2026
Aortic displacement and hemodynamics are abnormal in patients with Marfan syndrome: a combined 4D bSSFP and 4D flow CMR studyD Bosshardt, R Merton, A J Nederveen, et al.
European Heart Journal|March 11, 2025
Epicardial adipose tissue and malignant ventricular arrhythmias in phospholamban p.(Arg14del) variant carriersBelend Mahmoud, Moniek G P J Cox, Remco de Brouwer, et al.
Haematologica|December 21, 2023
Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapyWillem P J Cox, Nils Evander, Dorette S Van Ingen Schenau, et al.
Journal of Cardiovascular Electrophysiology|April 1, 2008
Activation delay and VT parameters in arrhythmogenic right ventricular dysplasia/cardiomyopathy: toward improvement of diagnostic ECG criteriaMoniek G P J Cox, Marcel R Nelen, Arthur A M Wilde, et al.
Medchemcomm|August 16, 2018
The discovery of a potent Na<sub>v</sub>1.3 inhibitor with good oral pharmacokineticsD C Pryde, N A Swain, P A Stupple, et al.
European Journal of Preventive Cardiology|February 19, 2025
The Role of Comorbidities and Lifestyle Factors in Disease Progression of Phospholamban CardiomyopathyBelend Mahmoud, Myrthe Y C van der Heide, Moniek G P J Cox, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|October 31, 2025
Three-dimensional distensibility of the aorta derived from four-dimensional cardiovascular magnetic resonance in young and middle-aged adults with Marfan syndromeDaan Bosshardt, Renske Merton, Bibi A Schreurs, et al.
Journal of Cardiovascular Electrophysiology|December 3, 2024
Arrhythmogenic Cardiomyopathy: Towards Genotype Based Diagnoses and ManagementSteven A Muller, Giorgia Bertoli, Jianan Wang, et al.
Cardiology|November 14, 2012
Clinical and genetic characterization of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy caused by a plakophilin-2 splice mutationJasper J van der Smagt, Paul A van der Zwaag, J Peter van Tintelen, et al.
Heart Rhythm|December 29, 2012
Left-dominant arrhythmogenic cardiomyopathy in a large family: associated desmosomal or nondesmosomal genotype?Judith A Groeneweg, Paul A van der Zwaag, Jan D H Jongbloed, et al.
Pageof 14